US Closed System Drug Transfer Device Market Research Report: By Type (Membrane to Membrane, Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based Devices, Air Filtration Devices) and By End-Users (Hospitals & Clinics, Specialty Centers, Others) - Forecast to 2035

US Closed System Drug Transfer Device Market

As per MRFR analysis, the US Closed System Drug Transfer Device Market Size was estimated at 262.15 (USD Million) in 2023. The US Closed System Drug Transfer Device Market Industry is expected to grow from 294(USD Million) in 2024 to 3,245 (USD Million) by 2035. The US Closed System Drug Transfer Device Market CAGR (growth rate) is expected to be around 24.396% during the forecast period (2025 - 2035).

Key US Closed System Drug Transfer Device Market Trends Highlighted

The US Closed System Drug Transfer Device (CSTD) market is experiencing significant growth driven by the increasing awareness of drug safety and the need to minimize exposure to hazardous drugs among healthcare workers. Strict regulations set by the Occupational Safety and Health Administration (OSHA) and the National Institute for Occupational Safety and Health (NIOSH) are echoing the importance of using CSTDs in healthcare settings, thus propelling market demand. Additionally, the ongoing trend of improving aseptic practices and reducing the risk of contamination during drug preparation and administration is enhancing the adoption of these devices across hospitals and pharmacies in the US.

Opportunities within the US market include the development of innovative, more user-friendly CSTDs that integrate advanced technology, potentially leading to improved efficiency and safety. Manufacturers are encouraged to explore partnerships with healthcare institutions to further educate practitioners on the benefits of CSTDs, ultimately increasing product uptake. Moreover, as healthcare systems continue to focus on patient-centric approaches, devices that offer enhanced safety features and ease of use are likely to see increased demand.

Recent trends in the US indicate a growing preference for automated and electronic systems that streamline the drug transfer process. These systems can help reduce human error and improve healthcare outcomes, reflecting the ongoing transformation in the pharmaceutical delivery framework. Additionally, the push towards sustainable healthcare practices presents an opportunity for manufacturers to develop environmentally friendly packaging for CSTDs. The combination of these trends and drivers positions the US Closed System Drug Transfer Device market for substantial evolution and growth in the coming years.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Closed System Drug Transfer Device Market Drivers

Increase in Chemotherapy Treatments

The rise in chemotherapy treatments for cancer patients is a significant driver for the US Closed System Drug Transfer Device Market Industry. The American Cancer Society reported an increase of approximately 1.9 million new cancer cases diagnosed in the US in 2021, which shows a growing need for effective drug administration systems. Furthermore, with advancements in targeted therapies, more patients are expected to undergo such treatments, thereby increasing the demand for Closed System Drug Transfer Devices (CSTDs) to minimize exposure to hazardous drugs.

Organizations such as the National Cancer Institute actively promote the use of safety measures in drug administration, which further supports the growth of the US Closed System Drug Transfer Device Market.

Regulatory Support for Drug Safety

Regulatory bodies, including the United States Food and Drug Administration (FDA), are increasingly emphasizing the importance of safety in drug administration. With the FDA's 2020 safety alert highlighting the role of CSTDs in reducing the risk of hazardous drug exposure to healthcare workers, there is an upward trend in adopting these devices in hospitals and clinics. This initiative reflects a significant shift in policy aimed at enhancing patient and worker safety, driving growth in the US Closed System Drug Transfer Device Market.

Rising Awareness of Occupational Safety

There is heightened awareness regarding Occupational Safety and Health Administration (OSHA) regulations among healthcare providers, which is propelling the adoption of Closed System Drug Transfer Devices. According to OSHA standards, exposure to hazardous drugs can lead to serious health risks, creating a growing demand for safety measures in drug administration processes. The increasing compliance with these regulations by healthcare organizations is expected to positively impact the growth of the US Closed System Drug Transfer Device Market, as hospitals seek to minimize risks in their drug-handling procedures.

Technological Advancements in Drug Delivery Systems

Technological advancements in drug delivery systems, particularly in the design and functionality of Closed System Drug Transfer Devices, are fostering market growth. Innovations such as prefilled syringes, automated devices, and improved barrier technologies are being developed to enhance safety and efficiency. As reported by the Health Resources and Services Administration, the US healthcare system is increasingly investing in Research and Development to advance drug delivery technology.

This investment signals a strong prospect for the US Closed System Drug Transfer Device Market, as healthcare providers look to integrate cutting-edge technology to improve patient care.

US Closed System Drug Transfer Device Market Segment Insights

Closed System Drug Transfer Device Market Type Insights

The US Closed System Drug Transfer Device Market is characterized by its diverse segmentation, particularly within the 'Type' category, which includes critical elements such as Membrane to Membrane and Needleless Systems. These device types play an essential role in enhancing safety and efficiency during drug transfer processes, especially in healthcare environments where contamination and exposure to hazardous materials pose significant risks. Membrane to Membrane systems are particularly notable for their ability to provide a secure and sterile environment, effectively minimizing the risk of drug leakage or aerosolization, which is a growing concern in the medical field.

The importance of these systems is underscored by various regulatory guidelines that encourage their adoption to safeguard healthcare professionals and patients alike. On the other hand, Needleless Systems are gaining traction as they drastically reduce the need for needles, which leads to fewer needle-stick injuries and consequently enhances safety standards in medical settings. This is particularly significant in the US, where the Centers for Disease Control and Prevention (CDC) highlights the impact of needle-stick injuries on healthcare workers.

The driving forces behind the increasing adoption of these device types include growth in the biopharmaceutical industry, a shift towards home healthcare settings, and rising regulatory frameworks aimed at improving occupational safety. Furthermore, the imperative to develop sophisticated drug delivery mechanisms to combat chronic diseases and ensure effective medication administration is pushing innovation in both these types of devices. Overall, the segmentation by 'Type' in the US Closed System Drug Transfer Device Market reveals vital insights into market dynamics, highlighting the crucial role of Membrane to Membrane and Needleless Systems in promoting safety and operational efficacy in drug handling and administration.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Closed System Drug Transfer Device Market Component Insights

The US Closed System Drug Transfer Device Market is significantly driven by its Component segment, which includes essential categories such as Vial Access Devices, Syringe Safety Devices, Accessories, and Bag/Line Access Devices. These components play a crucial role in enhancing the safety and efficacy of drug transfer processes, thereby reducing the risk of contamination and exposure to hazardous drugs. Vial Access Devices are pivotal as they allow safe access to medication vials, ensuring sterility during the drug preparation phase. Similarly, Syringe Safety Devices are vital for minimizing needle-stick injuries among healthcare professionals, aligning with growing safety regulations across healthcare settings.

Accessories complement the use of primary devices, while Bag/Line Access Devices contribute to the routing of medications without compromising safety standards. The increasing emphasis on patient safety, alongside advancements in technology, has led to a surge in demand for these devices in the US, further driving the evolution of the Closed System Drug Transfer Device Market. The focus on regulatory compliance and the need for efficient drug transfer systems to meet the healthcare industry's stringent safety requirements are expected to bolster growth in this segment, positioning it as a significant contributor to the overall market.

Closed System Drug Transfer Device Market Closing Mechanism Insights

The US Closed System Drug Transfer Device Market encompasses various crucial mechanisms, with the Closing Mechanism playing a pivotal role in ensuring safety and effectiveness in drug transfer processes. The Push to Turn System is recognized for its simplicity and reliability, making it a preferred choice among healthcare providers for preventing leakage and contamination. Similarly, the Color-to-color Alignment System enhances user confidence by providing visual cues for proper connection, thereby reducing the risk of errors during drug preparation.

Leur Lock Systems are significant due to their versatility and compatibility with various syringes, which is essential in the fast-paced medical environment. Moreover, Click to Lock Systems are also emerging as popular options due to their intuitive design, which provides an audible confirmation of secure connections and assures healthcare professionals of a safe and leak-proof environment. Collectively, these mechanisms enhance the overall safety profile of drug transfer operations, addressing critical market needs amidst increasing regulations and rising awareness regarding drug safety and patient protection in the US healthcare landscape. The continuous improvements in these technologies signify a promising outlook for the US Closed System Drug Transfer Device Market.

Closed System Drug Transfer Device Market Technology Insights

The Technology segment of the US Closed System Drug Transfer Device Market focuses on various innovative solutions that enhance drug safety and protect healthcare personnel from hazardous drug exposure. Within this segment, Compartmentalize Devices are significant due to their design that prevents cross-contamination, thereby improving the handling of both hazardous and non-hazardous substances. Diaphragm-Based Devices stand out for their effective sealing mechanisms, which play a vital role in minimizing the risk of leakage during drug transfer processes.

Furthermore, Air Filtration Devices are important in ensuring a sterile environment, mitigating exposure to airborne contaminants during drug handling. The integration of these technologies not only addresses safety concerns but also aligns with regulatory guidelines set forth by health authorities in the US. With the increasing focus on healthcare worker safety, the demand for these advanced solutions continues to rise, making the Technology segment a crucial component of the overall market landscape. The continuous evolution in technology and adherence to safety protocols highlight the significance and growth potential of these devices in safeguarding public health and improving clinical outcomes.

Closed System Drug Transfer Device Market End-Users Insights

The US Closed System Drug Transfer Device Market has a diverse array of End-Users, which plays a crucial role in the overall market dynamics. Hospitals and clinics represent a significant portion, as they serve as primary healthcare institutions where the administration of hazardous drugs is frequent, necessitating the usage of closed system drug transfer devices for ensuring safety and minimizing exposure risks. Specialty centers also hold considerable importance due to their focus on specific treatments that often involve high-risk medications, further driving the demand for safe drug transfer solutions in these settings.

The growing awareness of safety protocols and regulatory guidelines in the treatment of patients is propelling the adoption of closed system drug transfer devices across these End-Users. Meanwhile, other entities also contribute to the market by utilizing these devices to ensure compliance with safety standards and enhance operational efficiencies, reflecting a comprehensive approach to care across different healthcare environments. This segmentation highlights the varied applications and needs of each End-User, underscoring their importance in shaping the market landscape.

US Closed System Drug Transfer Device Market Key Players and Competitive Insights

The US Closed System Drug Transfer Device Market is characterized by a rapidly evolving landscape driven by increasing awareness regarding the safety of chemotherapy handling and management. This market consists of devices designed to mitigate risks associated with hazardous drug exposure among healthcare professionals and patients. A growing emphasis on occupational safety, coupled with stringent regulatory measures, has accelerated the adoption of closed system drug transfer devices (CSTD) across healthcare settings. Competitive dynamics within the market involve a blend of well-established players and emerging companies striving to innovate and capture market share. Companies engage in strategic partnerships, product development, and marketing campaigns that aim to highlight the efficacy and safety of their devices, positioning themselves as leaders in this essential market.

Equashield

Equashield is a notable player in the US Closed System Drug Transfer Device Market, focusing on the development and distribution of innovative solutions that ensure the safe handling of hazardous drugs. The company's primary strength lies in its ability to provide a comprehensive and integrated system that not only minimizes exposure risk but also enhances operational efficiency in healthcare settings. Equashield's presence in the US is marked by a robust network of healthcare partnerships, which facilitates the distribution of its products to a wide range of customer segments, including hospitals, oncology clinics, and other specialized healthcare facilities. By continually advancing its technology and maintaining a strong commitment to quality and safety, Equashield has carved a significant niche in the market that emphasizes both performance and reliability.

Vygon

Vygon, another key entity in the US Closed System Drug Transfer Device Market, specializes in comprehensive medical supply solutions that cater to healthcare professionals. The company offers a range of innovative products, including closed system drug transfer devices, designed to protect healthcare workers and patients from the dangers posed by hazardous drugs. Vygon's strengths lie in its extensive market presence and its dedication to quality, underpinned by a commitment to research and development. This ensures a consistent flow of innovative solutions tailored to the evolving needs of healthcare providers in the US. The company has also engaged in strategic mergers and acquisitions to expand its product portfolio and enhance its market presence, solidifying its position as a trusted supplier for healthcare settings looking for safe and effective drug transfer solutions. Vygon's ability to recognize and adapt to market demands has further enhanced its reputation, contributing to its competitive edge in the US market.

Key Companies in the US Closed System Drug Transfer Device Market Include

• Equashield


• Vygon


• MediPump


• Baxter International


• West Pharmaceutical Services


• GrahamField Health Products


• B. Braun Melsungen


• PhaSeal


• Medventive


• ICU Medical


• SafeMan


• Vallon Pharmaceuticals


• Corvida Medical


• C3S


• BD

US Closed System Drug Transfer Device Market Industry Developments

The US Closed System Drug Transfer Device Market is witnessing significant developments as of late 2023. The demand for safer drug handling in healthcare settings is escalating due to increasing regulatory scrutiny and a heightened focus on patient safety. Companies like Baxter International and ICU Medical are expanding their product offerings to meet these requirements. In recent competitive moves, West Pharmaceutical Services is developing innovative solutions to enhance drug delivery efficacy. In terms of mergers and acquisitions, Equashield announced a strategic acquisition of a smaller biotech firm focused on improving drug transfer technologies in October 2023, while B. Braun Melsungen completed the acquisition of a niche manufacturer to fortify its market presence in August 2023. The market continues to grow, driven by technological advancements and a 15% increase in market valuation noted from 2021 to 2023. Furthermore, ongoing regulatory updates from the FDA aim to bolster safety standards for closed drug transfer systems. With the industry's focus on reducing the risk of exposure to hazardous drugs, manufacturers are prioritizing Research and Development to innovate safer solutions for healthcare providers.

US Closed System Drug Transfer Device Market Segmentation Insights

Closed System Drug Transfer Device Market Type Outlook

• Membrane to Membrane


• Needleless System

Closed System Drug Transfer Device Market Component Outlook

• Vial Access Devices


• Syringe Safety Devices


• Accessories


• Bag/Line Access Devices

Closed System Drug Transfer Device Market Closing Mechanism Outlook

• Push to Turn System


• Color-to-color Alignment System


• Leur Lock Systems


• Click to Lock Systems

Closed System Drug Transfer Device Market Technology Outlook

• Compartmentalize Devices


• Diaphragm-Based Devices


• Air Filtration Devices

Closed System Drug Transfer Device Market End-Users Outlook

• Hospitals & Clinics


• Specialty Centers


• Others

Report Scope:

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	262.15(USD Million)
MARKET SIZE 2024	294.0(USD Million)
MARKET SIZE 2035	3245.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	24.396% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Equashield, Vygon, MediPump, Baxter International, West Pharmaceutical Services, GrahamField Health Products, B. Braun Melsungen, PhaSeal, Medventive, ICU Medical, SafeMan, Vallon Pharmaceuticals, Corvida Medical, C3S, BD
SEGMENTS COVERED	Type, Component, Closing Mechanism, Technology, End-Users
KEY MARKET OPPORTUNITIES	Rising demand for safety regulations, Increasing chemotherapy drug usage, Growing awareness of hazardous drug handling, Technological advancements in device design, Expansion in home healthcare settings
KEY MARKET DYNAMICS	Increasing adoption of safety protocols, Rising awareness of drug contamination, Regulatory compliance and approval requirements, Growing emphasis on healthcare worker safety, Technological advancements in device design
COUNTRIES COVERED	US